Convention Name Contributors
Stephanie Diaz – Vida Strategic Companions, Inc.
Steven Seedhouse – Cantor Fitzgerald & Co., Analysis Division
Joon Lee – Truist Securities, Inc., Analysis Division
Ryan Deschner – Raymond James & Associates, Inc., Analysis Division
Annabel Samimy – Stifel, Nicolaus & Firm, Included, Analysis Division
Hardik Parikh – JPMorgan Chase & Co, Analysis Division
Jay Olson – Oppenheimer & Co. Inc., Analysis Division
Mayank Mamtani – B. Riley Securities, Inc., Analysis Division
Rohit Bhasin – Morgan Stanley, Analysis Division
Yale Jen – Laidlaw & Firm (UK) Ltd., Analysis Division
Jiale Track – Jefferies LLC, Analysis Division
Tsan-Yu Hsieh – William Blair & Firm L.L.C., Analysis Division
Justin Zelin – BTIG, LLC, Analysis Division
Presentation
Operator
Welcome to the Viking Therapeutics Third Quarter 2025 Monetary Outcomes Convention Name. [Operator Instructions] As a reminder, this convention name is being recorded immediately, October 22, 2025.
I’d now like to show the convention over to Viking’s Supervisor of Investor Relations, Stephanie Diaz. Please go forward, Stephanie.
Stephanie Diaz
Vida Strategic Companions, Inc.
Whats up, and thanks all for taking part in immediately’s name. Becoming a member of me immediately is Brian Lian, Viking’s President and CEO; and Greg Zante, Viking’s CFO.
Earlier than we start, I would wish to warning that feedback made throughout this convention name immediately, October 22, 2025, will comprise forward-looking statements beneath the secure harbor provisions of the U.S. Personal Securities Litigation Reform Act of 1995, together with statements about Viking’s expectations concerning its improvement actions, time strains and milestones.
Ahead-looking statements are topic to dangers and uncertainties that might trigger precise outcomes to vary materially and adversely and reported outcomes shouldn’t be thought of as a sign of future efficiency. These forward-looking statements communicate solely as